立方制药 (003020)

Hefei Lifeon Pharmaceutical Co., Ltd.

ASZ

Tags

Chemical PharmaceuticalsMedical Aesthetics ConceptNew Social Security Fund HoldingsHigh-Performing StocksBonus Share PotentialStable Growth IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexWholesale & Retail IndexSME Board Composite IndexAnhui

K-Line Chart

No K-line data available

Company NameHefei Lifang Pharmaceutical Co., Ltd.
Listing Date2020-12-15
Issue Price23.13RMB
Registered Capital19018.218210k RMB
Legal RepresentativeJi Junqiu
Registered AddressLifang Factory Area, No. 669 West Changjiang Road, Hefei City, Anhui Province
IndustryChemical Pharmaceuticals
Main BusinessThe company is an innovative pharmaceutical enterprise integrating the R&D, production, and sales of pharmaceutical preparations and active pharmaceutical ingredients (APIs), as well as the wholesale and retail of pharmaceuticals and medical devices.
Company ProfileHefei Lifang Pharmaceutical Co., Ltd. was founded in 2002. It is an innovative pharmaceutical enterprise integrating the R&D, production, and sales of pharmaceutical preparations and active pharmaceutical ingredients (APIs), as well as the wholesale and retail of pharmaceuticals and medical devices. It covers the entire industry chain of pharmaceutical manufacturing and pharmaceutical commerce. Its main industrial products involve cardiovascular drugs, digestive system drugs, topical dermatological drugs, endocrine system drugs, and other fields. Lifang Pharmaceutical owns 4 industrial enterprises, 1 pharmaceutical commercial enterprise, and 1 drug retail chain enterprise, with over 800 employees in total. Currently, the company has obtained 25 invention patents and has successively received honors such as "National Torch Program Key High-Tech Enterprise," "Anhui Innovative Enterprise," "Provincially Recognized Enterprise Technology Center," "China's Most Valuable Pharmaceutical Enterprise for Investment," "Anhui Specialized, Refined, Distinctive, and New SME," "Anhui Provincial Drug Sustained-Release Engineering Technology Center," and "Hefei Intellectual Property Demonstration Enterprise." Both the company's industrial and commercial enterprises are recipients of the "Anhui Pharmaceutical Quality Award" and "Double Excellence Award," are Anhui Grade-A Taxpaying Enterprises, and are Anhui Contract-Honoring and Credit-Valued Units. The company has established an Anhui Postdoctoral Research Workstation and is the legal entity of the Anhui Pharmaceutical Industry Association and a Vice President Unit of the China Chemical Pharmaceutical Industry Association.

Stock Details

1. Key Indicators

  • Total Shares(W): 19018.22
  • Circulating A-Shares(W): 13772.45
  • Earnings Per Share(RMB): 0.6400
  • Net Assets Per Share(RMB): 9.4591
  • Operating Revenue(W RMB): 108068.61
  • Total Profit(W RMB): 13686.36
  • Net Profit Attributable to Parent(W RMB): 12094.17
  • Net Profit Growth Rate(%): 1.65
  • Weighted Return on Equity(%): 6.7900
  • Operating Cash Flow Per Share(RMB): 0.9890
  • Undistributed Profit Per Share(RMB): 5.2880
  • Capital Reserve Per Share(RMB): 2.6602

2. Main Business

The main business covers:

  • Pharmaceutical Industry
  • Pharmaceutical Commerce

3. Company Basic Information

  • Company Name: Hefei Lifeon Pharmaceutical Co., Ltd.
  • Listing Date: 2020-12-15
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 669 Changjiang West Road, Hefei City, Anhui Province, Lifeon Factory Area
  • Website: www.lifeon.cn
  • Company Profile：On August 1, 2010, Guofu Haohua Certified Public Accountants Co., Ltd. issued the audit report "Haohua Audit No. [2010] 1185", confirming that the audited net assets of Lifeon Co., Ltd. as of June 30, 2010 were RMB 68,078,913.97. On August 15, 2010, approved by the shareholders' meeting of Lifeon Co., Ltd., Lifeon Co., Ltd. was converted into a joint-stock company by changing its entire structure based on the audited net assets of RMB 68.0789 million as of June 30, 2010, of which RMB 66.00 million was converted into 66 million shares, and RMB 2.0789 million was included in capital reserve. On the same day, all promoters jointly signed the "Promoter Agreement". On August 30, 2010, all promoters held the founding meeting of Hefei Lifeon Pharmaceutical Co., Ltd., reviewed and approved the "Report on the Preparation of Hefei Lifeon Pharmaceutical Co., Ltd.", "Report on the Legal Overall Change of Hefei Lifeon Pharmaceutical Co., Ltd. into a Joint-Stock Company and the Capital Contribution of Each Promoter", "Report on the Establishment Expenses of Hefei Lifeon Pharmaceutical Co., Ltd.", and adopted the company's articles of association, elected the directors of the first board of directors and the shareholder representative supervisors of the first board of supervisors. On August 20, 2010, Guofu Haohua Certified Public Accountants Co., Ltd. issued the capital verification report "Haohua Verification No. [2010] 82", verifying that Lifeon Pharmaceutical (preparatory) received the registered capital of RMB 66.00 million paid by all promoters. On August 30, 2010, the company obtained the "Business License of Enterprise Legal Person" issued by the Hefei Administration for Industry and Commerce with the registration number "340106000026030".

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hefei Lifeon Investment Group Co., Ltd. General Legal Person 3747.74 27.21
2 China Merchants Fund Management Co., Ltd. - Social Security Fund 2108 Portfolio Social Security Fund 101.39 0.74
3 Invesco Great Wall Medical Health Hybrid Securities Investment Fund Class A Fund 91.01 0.66

5. Concept Sectors

  • Medical Aesthetics Concept
  • Hepatitis Concept
  • Innovative Drug
  • High-Performance Stock
  • Potential for Bonus Issue/Transfer
  • New Social Security Fund Holdings

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information